guidance | Page 2

Business News

Is it Time to Cash Out Novavax Stock?

Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company's protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S.
By Jea Yu
Business News

Accolade Moves Higher But Growth Is Slowing

Accolade (NASDAQ: ACCD) is certainly an interesting play on the health care space providing business and employee services geared toward helping clients navigate the cumbersome health benefits arena. The pandemic...
Business News

Wix.com Stock Nearing a Bottom Wick

Website development platform Wix.com (NASDAQ: WIX) stock has seen a dramatic (-64%) sell-off in shares year-to-date losing more than twice the NASDAQ drop.
By Jea Yu
Business News

Nutanix Stock Bestows a Cheap Entry

Enterprise hybrid mullticloud computing platform Nutanix (NASDAQ: NTNX) stock was a unicorn on its IPO but has plunged like a rock down (-47%) on the year.
By Jea Yu
Business News

Macys Stock is Ready to Buy

Retail department store chain Macy's (NYSE: M) stock has been weathering the bear market in retail stocks after posting stellar fiscal Q1 2022 earnings and raising guidance.
By Jea Yu